Novel neuroprotective drug improves recovery after acute ischemic stroke
New Hope for Stroke Recovery: Loberaisal Shows Promise in Phase III Trial A novel neuroprotective medication, loberamisal, is offering a glimmer of hope for stroke patients. Preliminary results from a Phase III clinical trial presented at the American Stroke Association’s International Stroke Conference 2026 in New Orleans suggest that early intervention with loberamisal can significantly … Read more